Physiopathology of rosacea. Redness, telangiectasia, and rosacea

被引:0
|
作者
Cribier, B. [1 ,2 ]
机构
[1] Univ Strasbourg, Dermatol Clin, Fac Med, F-67091 Strasbourg, France
[2] Hop Univ Strasbourg, F-67091 Strasbourg, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2011年 / 138卷
关键词
Rosacea; Facial telangiectasia; Demodex folliculorum; Innate immunity; Telangiectasias; GROWTH-FACTOR; ANGIOGENESIS; PATHOGENESIS; RHINOPHYMA; CELLS;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The physiopathology of rosacea involves a large number of factors that are at times difficult to correlate. There is not a single physiopathological model. Nevertheless, today it seems to have been established that two essential factors are involved: vascular and inflammatory. The disease occurs in individuals with a predisposition, mainly a light phototype subjected to substantial variations in climate. On a background of primary vascular anomaly, external factors (climate, exposure to ultraviolet rays, cutaneous flora, etc.) contribute to the development of abnormal superficial blood vessels, with a low permeability. The edema that results undoubtedly favors the colonization and multiplication of Demodex folliculorum. This parasite creates inflammation, directly and indirectly, which is seen in the papules and pustules as well as granulomas. Inflammation from rosacea is also characterized by innate immune system anomalies, with an increase in the expression of epidermal proteases and production of pro-inflammatory cathelicidin peptides. In addition, facial hypersensitivity exists, even though the cutaneous barrier is not altered. Finally, rhinophyma remains poorly explained; the vascular abnormalities induce local production of transforming growth factor B 1 (TGF-B1) capable of creating fibrosis and therefore cutaneous thickening. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S129 / S137
页数:9
相关论文
共 50 条
  • [1] Physiopathology of rosacea
    Cribier, B.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 : S158 - S164
  • [2] Medical Management of Facial Redness in Rosacea
    Cline, Abigail
    McGregor, Sean P.
    Feldman, Steven R.
    DERMATOLOGIC CLINICS, 2018, 36 (02) : 151 - +
  • [3] Steroid-aggravated rosacea. Successful therapy with pimecrolimus
    Meykadeh, N.
    Meiss, F.
    Marsch, W. C.
    Fischer, M.
    HAUTARZT, 2007, 58 (04): : 338 - 341
  • [4] Rosacea: Treatment targets based on new physiopathology data
    Cribier, B.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (02): : 99 - 107
  • [5] Rosacea
    Webster, Guy F.
    MEDICAL CLINICS OF NORTH AMERICA, 2009, 93 (06) : 1183 - +
  • [6] Xanthone Derivatives and Their Potential Usage in the Treatment of Telangiectasia and Rosacea
    Brezden, Katarzyna
    Waszkielewicz, Anna M.
    APPLIED SCIENCES-BASEL, 2024, 14 (10):
  • [7] Validation of a Photonumeric Scale for Evaluation of Telangiectasia in Rosacea
    Nguyen, Lynhda
    Seeber, Nikolaus
    Baron, Jens M.
    Hammes, Stefan
    Karsai, Syrus
    Fischer, Tanja C.
    Imhof, Laurence
    Kautz, Gerd
    Sattler, Sonja
    Deussing, Maximilian
    Dierckxsens, Cathy
    Thiem, Alexander
    Drosos, Zacharias
    Grosse-Buening, Stephan
    Ganjuur, Nomun
    Kampmann, Anna-Sophie
    May, Johanna K.
    Schneider, Stefan W.
    Kerscher, Martina
    Herberger, Katharina
    JOURNAL OF COSMETIC DERMATOLOGY, 2025, 24 (01)
  • [8] Laser treatment of erythema and telangiectasia associated with rosacea
    Clark, SM
    Lanigan, SW
    Marks, R
    LASERS IN MEDICAL SCIENCE, 2002, 17 (01) : 26 - 33
  • [9] Rosacea 2009
    Sobottka, A.
    Lehmann, P.
    HAUTARZT, 2009, 60 (12): : 999 - 1008
  • [10] Rosacea
    Searle, Tamara
    Al-Niaimi, Firas
    Ali, Faisal R.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (02)